The efficiency of a continuous versus an intermittent apheresis method for collection of hematopoietic progenitor stem cells: A systematic review

C Hobbs, H Green, R Fernandez - Journal of Clinical …, 2023 - Wiley Online Library
Peripheral blood hematopoietic progenitor stem cells (HPSCs) are the most common source
of stem cells for autologous and allogenic transplantation. Currently, systematic reviews …

Predictive model of the efficiency of hematopoietic stem cell collection in patients with multiple myeloma and lymphoma based on multiple peripheral blood markers

L Ran, Y Peng, M Zhao, X Luo, S Chen… - International Journal …, 2024 - Wiley Online Library
Introduction Autologous hematopoietic stem cell transplantation (ASCT) has gained
extensive application in the treatment of lymphoma and multiple myeloma (MM). Plenty of …

Selection of Stem Cell Source

C Horgan, D Valcárcel - The EBMT Handbook: Hematopoietic Cell …, 2024 - Springer
Selection of stem cell source is an important consideration for any physician planning an
allogeneic haematopoietic cell transplant (HCT) and has evolved considerably since bone …

Mobilization and Collection of HSC

N Worel, YM Bilgin, P Wuchter - The EBMT Handbook: Hematopoietic Cell …, 2024 - Springer
The intravenous infusion of patient's own HSC (autologous SCT) to restore BM damage is
the basic principle of high-dose chemotherapy, since otherwise the patient would expect …

[HTML][HTML] Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies

CA Villegas-Valverde, AA Bencomo-Hernandez… - … , Transfusion and Cell …, 2023 - Elsevier
Introduction Hematopoietic stem cell transplantation (HSCT) is a widely used therapy, but its
success largely depends on the number and quality of stem cells collected. Current …

Empfehlung für Leukozytapheresen zur CAR-T-Zell-Herstellung

N Worel, H Bonig - Transfusionsmedizin, 2024 - thieme-connect.com
Autologe chimäre Antigenrezeptor-modifizierte (CAR-) T-Zellen bieten erhebliche Vorteile
für Patienten mit ansonsten refraktären malignen Erkrankungen. Die derzeit zugelassenen …